Skip to main content

Table 5 Univariate and multivariate Cox analysis of PFS among patients who received EGFR-TKI treatment

From: Effects of reduced platelet count on the prognosis for patients with non-small cell lung cancer treated with EGFR-TKI: a retrospective study

  Univariate analysis Multivariate analysis
HR 95%CI P HR 95%CI P
Platelet
 (Decrease VS Increase) 0.592 0.325-1.080 0.087    
D-dimer
 (Decrease VS Increase) 0.733 0.387-1.391 0.342    
 Male VS Female 0.728 0.399-1.326 0.299    
 Age (≥62.5 vs. others) 1.104 0.617-1.976 0.738    
Substitution in exon 21
 (Yes vs. No) 0.934 0.489-1.787 0.837    
Deletion in exon 19
 (Yes vs. No) 1.392 0.774-2.502 0.269    
 Smoking(Yes vs. No) 1.360 0.728-2.539 0.335    
Other treatment
 (Yes vs. No) 0.691 0.377-1.266 0.231    
Other diseases
 (Yes vs. No) 1.254 0.695-2.263 0.452    
  1. PFS progression-free survival, HR hazard ratio
\